One MG RCT publication reported an improvement in ‘pain-at-its worst’ scores with agalsidase alfa 0.1 mg/kg/week and 0.2 mg/kg/week compared with pre-treatment levels, but no differences in mean pain score [135]. The gene discussed is GLA; the disease is myasthenia gravis.